HIF1A and glioblastoma: A study demonstrated that HIF1α is highly expressed in GBM cells, further promoting epithelial-mesenchymal transition (EMT), tumor invasion, and chemotherapy resistance, thereby exacerbating tumor malignancy (Liu et al., 2020).